CClinicalTrials.gg
TerminatedNCT03716687Updated Mar 22, 2021

Prophylactic Negative Pressure Wound Therapy for High Risk Laparotomy Wounds. A Randomized Prospective Clinical Trial.

An interventional study of Prophylactic negative pressure wound dressing after laparotomy in Surgical Wound, Wound Dehiscence, Surgical and Surgical Site Infection, sponsored by St. Borbala Hospital. Terminated at 1 site in Hungary. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2021-03-22.

Sponsored by St. Borbala Hospital · Not applicable, Interventional, and Prevention

Why this study was terminated
No chance to enroll sufficient cases. Several coinvestigator centers have never started recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Negative pressure wound closure technique (NPWT) has been widely introduced in different clinical settings. Most of the studies report it as an effective and cost-effective method to treat complicated surgical wounds or even open abdomen.

NPWT as a prophylactic effort to prevent complications of high risk surgical wounds has recently been introduced, but the concept is still lacking clinical evidence in terms of clinical effectiveness and cost effectiveness.

In this randomized, multi centric study investigators aim to compare prophylactic negative pressure wound closure (ciNPWT) with traditional, dry wound dressing at high infection risk laparotomy wounds.

Read the detailed description

The aim is to compare ciNPWT (closed incisional negative pressure wound dress) technique to the traditional, dry wound dressing technique at high infection risk laparotomy wounds.

Control arm will be treated "as usual": sterile gauze or high-absorbing surgical wound dress.

Experimental arm will be dressed with: one layer of silver-containing, impregnated mesh laxer (Atrauman® Ag - Hartmann) directly placed on the primary closed wound, one layer of alcohol-soaked foam (VivanoMed® White Foam - Hartmann) and sufficient-size sealant film (Hydrofilm® - Hartmann).

A negative pressure of -90 Hgmm will be administered in a continuous mode over 5 days postoperatively.

Surgical site infection and abdominal wall dehiscence rate will be assessed, as well as cost effectiveness will be calculated at both arms.

02

Conditions studied

  • Surgical Wound
  • Wound Dehiscence, Surgical
  • Surgical Site Infection
  • Dehiscence of Internal Surgical Wound

Keywords

  • negative pressure wound closure
  • surgical site infection
  • cost effectiveness
03

In context

Surgical Wound Infection

670 studies on the registry are indexed under Surgical Wound Infection; 141 are open to participants now.

This study's enrollment of 100 is below the median of 200 across 514 interventional studies indexed under Surgical Wound Infection.

Browse Surgical Wound Infection studies →

Lead sponsor

St. Borbala Hospital is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • High risk laparotomy patients. SSI risk at least 3x higher than normal rate (6-8%)
  • Surgical wound type III or IV..

Exclusion criteria

Exclusion Criteria:

  • Patients not giving informed consent.
  • Patients requiring open abdominal wound care.
  • Patients with abdominal wall malignancy,
  • Patients with peritoneal carcinomatosis,
  • Patients who are planned for second look laparotomy within 5 days,
  • Patients with less thank 3 month life expectancy.
  • Patients who are operated with existing wound infection
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    ciNPWT

    Prophylactic negative pressure wound dress (Hartmann) is set up for 5 days right after operation. Continous -90 Hgmm negative pressure mode selected. No change of wound dress until 5 days completed.

    Device: Prophylactic negative pressure wound dressing after laparotomy

  • No intervention
    Traditional wound dressing

    Control group with traditional, dry laparotomy wound dressing.

Interventions

  • DeviceProphylactic negative pressure wound dressing after laparotomy

    Five days of -90 Hgmm continuous negative pressure wound dressing left on primary closed laparotomy wound.

06

What researchers measure

Primary outcomes

  1. Surgical site infection

    Surgical site infection requiring wound re-opening (suture removal) and open wound treatment. (Clavien-Dindo 2)

    Time frame: 30 days

Secondary outcomes

  1. Full thickness abdominal wall dehiscence, requiring re-operation

    Full thickness abdominal wall dehiscence, requiring re-operation

    Time frame: 30 days

07

Study locations

1 site
  • St. Borbala Hospital
    Tatabánya, 2800, Hungary
08

References and documents

Publications

  • Sahebally SM, McKevitt K, Stephens I, Fitzpatrick F, Deasy J, Burke JP, McNamara D. Negative Pressure Wound Therapy for Closed Laparotomy Incisions in General and Colorectal Surgery: A Systematic Review and Meta-analysis. JAMA Surg. 2018 Nov 1;153(11):e183467. doi: 10.1001/jamasurg.2018.3467. Epub 2018 Nov 21. PubMed 30267040 ↗
  • Curran T, Alvarez D, Pastrana Del Valle J, Cataldo TE, Poylin V, Nagle D. Prophylactic closed-incision negative-pressure wound therapy is associated with decreased surgical site infection in high-risk colorectal surgery laparotomy wounds. Colorectal Dis. 2019 Jan;21(1):110-118. doi: 10.1111/codi.14350. Epub 2018 Aug 20. PubMed 30047611 ↗
  • Gachabayov M, You K, Sullivan R, Bergamaschi R. A Retrospective Cohort Study to Determine Predictive Factors for Abdominal Wound Disruption Following Colorectal Surgery. Ostomy Wound Manage. 2018 Apr;64(4):22-29. PubMed 29718814 ↗
  • Strugala V, Martin R. Meta-Analysis of Comparative Trials Evaluating a Prophylactic Single-Use Negative Pressure Wound Therapy System for the Prevention of Surgical Site Complications. Surg Infect (Larchmt). 2017 Oct;18(7):810-819. doi: 10.1089/sur.2017.156. Epub 2017 Sep 8. PubMed 28885895 ↗
  • Athanasiou AN, Spartalis M, Spartalis E. Prophylactic Negative Pressure Dressing Use in Closed Laparotomy Wounds After Abdominal Operations: What We Really Know? Ann Surg. 2018 Jul;268(1):e19-e20. doi: 10.1097/SLA.0000000000002413. No abstract available. PubMed 28692475 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 22, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03716687
Lead sponsor
St. Borbala Hospital
Collaborators
Semmelweis University, Department of Surgery, Jahn Ferend Dél-Pesti Kórház és Rendelőintézet, Budapest, Department of Surgery, Somogy Megyei Kaposi Mór Oktatókórház, Kaposvár, Institute of Surgery, University of Debrecen, Department of Surgery, University of Szeged, Department of Surgery, Uzsoki Utcai Kórház és Rendelőintézet, Budapest, Department of Surgery, Markusovszky Egyetemi Oktatókórház, Szombathely, Department of Surgery, Bács-Kiskun Megyei Kórház, Kecskemét, Department of Surgery, Kenézy Gyula Egyetemi Oktatókórház, Debrecen, Department of Surgery, Szent Rókus Kórház, Baja, Department of Surgery, St. Borbala hospital, Tatabanya
Responsible party
Dr. Balázs Bánky PhD (Head of the Department of Surgery, St. Borbala Hospital, St. Borbala Hospital) — Principal investigator
First posted
Oct 23, 2018
Start date
Nov 1, 2018
Primary completion
Jul 1, 2020
Completion
Sep 1, 2020
Last update
Mar 22, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion